These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9547441)

  • 1. Nebivolol in the treatment of cardiac failure: a double-blind controlled clinical trial.
    Uhlir O; Dvorak I; Gregor P; Malek I; Spinarova L; Vojacek J; Van Nueten L
    J Card Fail; 1997 Dec; 3(4):271-6. PubMed ID: 9547441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Influence of the beta-blocker nebivolol on left ventricular function in patients with chronic heart failure].
    Wolf SC; Buck-Müller N; Görner S; Risler T; Brehm BR
    Med Klin (Munich); 2003 Jan; 98(1):1-6. PubMed ID: 12540987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nebivolol vs atenolol and placebo in essential hypertension: a double-blind randomised trial.
    Van Nueten L; Taylor FR; Robertson JI
    J Hum Hypertens; 1998 Feb; 12(2):135-40. PubMed ID: 9504355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).
    Flather MD; Shibata MC; Coats AJ; Van Veldhuisen DJ; Parkhomenko A; Borbola J; Cohen-Solal A; Dumitrascu D; Ferrari R; Lechat P; Soler-Soler J; Tavazzi L; Spinarova L; Toman J; Böhm M; Anker SD; Thompson SG; Poole-Wilson PA;
    Eur Heart J; 2005 Feb; 26(3):215-25. PubMed ID: 15642700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nebivolol versus nifedipine in the treatment of essential hypertension: a double-blind, randomized, comparative trial.
    Van Nueten L; Lacourcière Y; Vyssoulis G; Korlipara K; Marcadet DM; Dupont AG; Robertson JI
    Am J Ther; 1998 Jul; 5(4):237-43. PubMed ID: 10099065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nebivolol: third-generation beta-blockade.
    de Boer RA; Voors AA; van Veldhuisen DJ
    Expert Opin Pharmacother; 2007 Jul; 8(10):1539-50. PubMed ID: 17661735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure (SENIORS). Rationale and design.
    Shibata MC; Flather MD; Böhm M; Borbola J; Cohen-Solal A; Dumitrascu D; Ferrari R; Lechat P; Parkhomenko A; Soler-Soler J; Tavazzi L; Toman J; Van Veldhuisen DJ; Coats AJ; Poole-Wilson P;
    Int J Cardiol; 2002 Nov; 86(1):77-85. PubMed ID: 12243852
    [No Abstract]   [Full Text] [Related]  

  • 8. Medium-term effects of beta-blockade on left ventricular mechanics: a double-blind, placebo-controlled comparison of nebivolol and atenolol in patients with ischemic left ventricular dysfunction.
    Rousseau MF; Chapelle F; Van Eyll C; Stoleru L; Hager D; Van Nueten L; Pouleur H
    J Card Fail; 1996 Mar; 2(1):15-23. PubMed ID: 8798100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nebivolol: a review.
    Cockcroft J
    Expert Opin Pharmacother; 2004 Apr; 5(4):893-9. PubMed ID: 15102571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nebivolol reverses endothelial dysfunction in essential hypertension: a randomized, double-blind, crossover study.
    Tzemos N; Lim PO; MacDonald TM
    Circulation; 2001 Jul; 104(5):511-4. PubMed ID: 11479245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nebivolol, a vasodilating selective beta(1)-blocker, is a beta(3)-adrenoceptor agonist in the nonfailing transplanted human heart.
    Rozec B; Erfanian M; Laurent K; Trochu JN; Gauthier C
    J Am Coll Cardiol; 2009 Apr; 53(17):1532-8. PubMed ID: 19389564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-blockade with nebivolol for prevention of acute ischaemic events in elderly patients with heart failure.
    Ambrosio G; Flather MD; Böhm M; Cohen-Solal A; Murrone A; Mascagni F; Spinucci G; Conti MG; van Veldhuisen DJ; Tavazzi L; Coats AJ
    Heart; 2011 Feb; 97(3):209-14. PubMed ID: 21138861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of the L-arginine/nitric oxide system in the action of nebivolol].
    Brodde OE; Philipp T
    Dtsch Med Wochenschr; 2006 Nov; 131(45):2545-50. PubMed ID: 17091442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nebivolol: a review of its use in the management of hypertension and chronic heart failure.
    Moen MD; Wagstaff AJ
    Drugs; 2006; 66(10):1389-409; discussion 1410. PubMed ID: 16903772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nebivolol: a beta blocker with vasodilator properties].
    Waeber B
    Praxis (Bern 1994); 2000 Apr; 89(15):631-3. PubMed ID: 10804847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the long-term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction: results of the ELANDD study.
    Conraads VM; Metra M; Kamp O; De Keulenaer GW; Pieske B; Zamorano J; Vardas PE; Böhm M; Dei Cas L
    Eur J Heart Fail; 2012 Feb; 14(2):219-25. PubMed ID: 22147202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nebivolol for the treatment of heart failure.
    Dery AS; Hamilton LA; Starr JA
    Am J Health Syst Pharm; 2011 May; 68(10):879-86. PubMed ID: 21546638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term (3-month) effects of a new beta-blocker (nebivolol) on cardiac performance in dilated cardiomyopathy.
    Wisenbaugh T; Katz I; Davis J; Essop R; Skoularigis J; Middlemost S; Röthlisberger C; Skudicky D; Sareli P
    J Am Coll Cardiol; 1993 Apr; 21(5):1094-100. PubMed ID: 8096228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure).
    van Veldhuisen DJ; Cohen-Solal A; Böhm M; Anker SD; Babalis D; Roughton M; Coats AJ; Poole-Wilson PA; Flather MD;
    J Am Coll Cardiol; 2009 Jun; 53(23):2150-8. PubMed ID: 19497441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nebivolol: a third-generation beta-blocker for hypertension.
    Cheng JW
    Clin Ther; 2009 Mar; 31(3):447-62. PubMed ID: 19393838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.